Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Safety and Adverse Events Related to Covid-19 Mrna Vaccines; a Systematic Review Publisher



Alinaghi SAS1 ; Karimi A2 ; Pashaei Z1 ; Afzalian A2 ; Ghorbanzadeh K3 ; Ghasemzadeh A4 ; Dashti M4 ; Nazarian N5 ; Vahedi F2 ; Tantuoyir MM2, 6 ; Shamsabadi A7 ; Dadras O1, 8
Authors

Source: Archives of Academic Emergency Medicine Published:2022


Abstract

Introduction: Knowledge of vaccine-related adverse events is crucial as they are among the most important factors that cause hesitation in receiving vaccines. Therefore, we aimed to systematically review the adverse events related to the mRNA vaccines reported in the literature. Methods: A systematic literature search was carried out in the databases of Scopus, PubMed, Cochrane, and Web of Science. We selected original studies that explored the side effects of mRNA COVID-19 vaccines using a two-phase (title/abstract and full-text) screening process. Results: Cardiac complications were the most commonly reported severe adverse events. It appeared that systemic adverse reactions are more common after the second dose of vaccines. The number of adverse effects reported after the Pfizer vaccine was higher than other vaccines, mostly due to its earlier approval and more widespread use throughout the world. Cardiac adverse events had a higher prevalence but no significant association has been found between COVID-19 mRNA vaccines and cardiac adverse events except for myopericarditis. Conclusion: Vaccines play a crucial role in controlling the COVID-19 pandemic and decreasing mortalities and the results of the present review acknowledge the fact that the benefits outweigh the adverse events of these vaccines © 2022. Archives of Academic Emergency Medicine.All Rights Reserved.
Other Related Docs
11. Ophthalmic Side Effects of Covid-19 Vaccines, Expert Review of Ophthalmology (2022)
20. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)